Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
University Health Network, Toronto
Eastern Cooperative Oncology Group
University of Kentucky
University of Kentucky
UCB Pharma
Hoffmann-La Roche
Duke University
Eli Lilly and Company
Mereo BioPharma
Eli Lilly and Company
Celgene
Merck Sharp & Dohme LLC
AbbVie
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
SCRI Development Innovations, LLC
Oncolytics Biotech
Amgen
Oncolytics Biotech
Oncolytics Biotech
Abbott
Amgen